Compare Estee Lauder Companies Inc (EL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs Tenet Healthcare Corporation — how do they compare? Estee Lauder Companies Inc trades at $82.49 (market cap $29.78B), while Tenet Healthcare Corporation trades at $199.06 (market cap $16.57B). The key difference: Estee Lauder Companies Inc is the larger of the two by market cap, and Estee Lauder Companies Inc pays a 1.7% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| EL | THC | |
|---|---|---|
Market Cap | $29.78B | $16.57B |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $244.80 |
52-Week Low | $67.23 | $148.38 |
Enterprise Value | $35.95B | $26.81B |
Dividend Yield | 1.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Estée Lauder (EL) trades at $82.72, up 2.3% with recent earnings beats but faces fundamental challenges including a negative net income margin of -1.67% and elevated P/E ratio of 147.8. Technical indicators show bearish momentum with support at $81 and resistance at $84. The company maintains strong gross margins at 74.71% and positive analyst sentiment with 44% buy ratings and $90.60 consensus target.
While recent earnings outperformance and strong brand positioning provide upside potential, investors face risks from declining revenue trends, negative profitability, and high valuation multiples. The stock's near-term direction will depend on Q2 2026 earnings delivery and management's ability to restore sustainable growth amid competitive pressures.
Tenet Healthcare (THC) trades at $198.46, up 8.04% in the last 24 hours, showing strong momentum. The stock is supported by a bullish analyst consensus with a $235.88 price target, while recent earnings have consistently beaten expectations. However, technical indicators signal a bearish short-term trend, with the price currently testing key support levels near $191.
The outlook is positive based on solid fundamentals, including a low P/E of 10 and strong profitability metrics like a 37.87% ROE. Key risks include market volatility ahead of Q2 2026 earnings on July 24 and potential macroeconomic pressures on the healthcare sector. The primary opportunity lies in the stock's attractive valuation relative to its growth and analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
